C4 Therapeutics (CCCC) PT Lowered to $16 at BMO Capital

November 2, 2023 6:41 AM EDT Send to a Friend

BMO Capital analyst Etzer Darout ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

C4 Therapeutics (CCCC) PT Lowered to $16 at BMO Capital

Member Login

Free News Feed